CA3205241A1 - Milk-derived exosome and extraction method therefor - Google Patents
Milk-derived exosome and extraction method therefor Download PDFInfo
- Publication number
- CA3205241A1 CA3205241A1 CA3205241A CA3205241A CA3205241A1 CA 3205241 A1 CA3205241 A1 CA 3205241A1 CA 3205241 A CA3205241 A CA 3205241A CA 3205241 A CA3205241 A CA 3205241A CA 3205241 A1 CA3205241 A1 CA 3205241A1
- Authority
- CA
- Canada
- Prior art keywords
- milk
- derived
- exosome
- clear liquid
- centrifuging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 107
- 235000013336 milk Nutrition 0.000 title claims abstract description 80
- 210000004080 milk Anatomy 0.000 title claims abstract description 80
- 239000008267 milk Substances 0.000 title claims abstract description 80
- 238000000605 extraction Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 47
- 239000007788 liquid Substances 0.000 claims abstract description 33
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 19
- 239000007853 buffer solution Substances 0.000 claims abstract description 14
- 239000002244 precipitate Substances 0.000 claims abstract description 14
- 235000020185 raw untreated milk Nutrition 0.000 claims abstract description 13
- 238000000926 separation method Methods 0.000 claims abstract description 9
- 238000011534 incubation Methods 0.000 claims abstract description 8
- 239000006228 supernatant Substances 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 230000008569 process Effects 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 238000004458 analytical method Methods 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 23
- 238000005119 centrifugation Methods 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108091070501 miRNA Proteins 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 108091028075 Circular RNA Proteins 0.000 description 2
- 108091046869 Telomeric non-coding RNA Proteins 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 102100027221 CD81 antigen Human genes 0.000 description 1
- 102100027217 CD82 antigen Human genes 0.000 description 1
- 102100037904 CD9 antigen Human genes 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
- 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108700031126 Tetraspanins Proteins 0.000 description 1
- 102000043977 Tetraspanins Human genes 0.000 description 1
- 108010033576 Transferrin Receptors Proteins 0.000 description 1
- 102000007238 Transferrin Receptors Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000023402 cell communication Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
Abstract
The present application relates to a method for extracting milk-derived exosomes. The method sequentially comprises the following steps: (1) subpackaging and centrifuging raw milk, and collecting a clear liquid; (2) centrifuging the clear liquid obtained in step (1), and collecting a clear liquid in the middle layer; (3) centrifuging the clear liquid in the middle layer obtained in step (2), collecting a clear liquid, mixing the collected clear liquid with a PBS buffer solution and an exosome extraction reagent uniformly, and performing incubation; (4) centrifuging the product of step (3), retaining the precipitate, and re-suspending the precipitate with a PBS buffer solution; and (5) centrifuging the product of step (4) and collecting the supernatant to obtain the milk-derived exosome. Compared with milk-derived exosomes prepared by other methods, the milk-derived exosome prepared by the method for extracting milk-derived exosomes provided in the present application is more complete in morphology, requires less sample volume, and contains more types of milk-derived exosome proteins after separation, which is more conducive to analysis and research work.
Description
MILK-DERIVED EXOSOME AND EXTRACTION METHOD THEREFOR
CROSS-REFERENCE
The present application claims priority to Chinese patent application titled "MILK-DERIVED
EXOSOME AND EXTRACTION METHOD THEREFOR" and filed with the China Patent Office, with the application number of 2022107559493 and the application date of June 30, 2022, the entire contents of which are incorporated herein by reference.
Technical Field The present application relates to the technical field of dairy products, in particular to a milk-derived exosome and an extraction method therefor.
Background Art Exosomes are round or oval vesicles with double-membrane structures actively secreted by cells, with a diameter of 30-200 nm and a density of 1.13-1.19 g/mL. In 1983, small vesicles of 50 nm were discovered for the first time in the study of transferrin receptors in reticulocytes. In 1987, the Canadian scholar Rose Johnstone created the word "Exosome" and believed that exosomes are just a tool for the "excretion" of cells into the external environment. In 2007, Valadi et al.
proposed that exosomes contain mRNA and miRNA and can transmit them to another cell. Since then, the functions and mechanisms of exosomes started to be extensively studied. Exosomes exist in various body fluid environments such as serum, urine, saliva, milk and amniotic fluid.
Exosomes in biological fluids indicate the functional states of their origin cells, and can be used as bio-diagnostic markers for liver cancer, prostate cancer and other diseases in medicine. Since the membrane structures of exosomes can also be used as a drug carrier to exhibit high-efficiency drug delivery characteristics, for example, exosomes where unstable curcumin are loaded can improve the therapeutic effect.
Milk-derived exosomes are small vesicles secreted by mammary epithelial cells, and their main components are proteins, lipids and nucleic acids. The membrane surfaces of milk-derived exosomes have specific membrane proteins, such as the most abundant tetraspanins (CD9, CD82, CD81 and CD63), co-stimulatory molecules (CD54) and adhesion molecules (CD11b). Lipids (phosphatidylcholine, phosphatidylserine, phosphatidylethanolarnine, sphingomyelin, and phosphatidylinositol) are also commonly found in exosomes. Nucleic acids in milk-derived exosomes mainly comprise non-coding single-stranded RNA molecules (micro RNA, miRNA), long non-coding RNA (lncRNA), circular RNA (circRNA), mRNA and tRNA, etc. Milk-derived Date Recue/Date Received 2023-06-30 exosomes play an important role in physiological processes, such as mediating cell communication, promoting cell growth, and participating in immune responses.
At present, the commonly used exosome separation technology is centrifugation, but centrifugation would damage the morphologies of exosomes.
In view of this, the present application is hereby provided.
Summary of the Invention In order to solve the existing technical problems, the present application provides a new method for extracting milk-derived exosomes, and the method has little influence on the morphologies of exosomes.
In order to achieve the above-mentioned object, the technical solution used in the present application is as follows:
In a first aspect, the present application provides a method for extracting milk-derived exosomes.
The method sequentially comprises the following steps:
(1) Subpackaging and centrifuging raw milk, and collecting a clear liquid;
CROSS-REFERENCE
The present application claims priority to Chinese patent application titled "MILK-DERIVED
EXOSOME AND EXTRACTION METHOD THEREFOR" and filed with the China Patent Office, with the application number of 2022107559493 and the application date of June 30, 2022, the entire contents of which are incorporated herein by reference.
Technical Field The present application relates to the technical field of dairy products, in particular to a milk-derived exosome and an extraction method therefor.
Background Art Exosomes are round or oval vesicles with double-membrane structures actively secreted by cells, with a diameter of 30-200 nm and a density of 1.13-1.19 g/mL. In 1983, small vesicles of 50 nm were discovered for the first time in the study of transferrin receptors in reticulocytes. In 1987, the Canadian scholar Rose Johnstone created the word "Exosome" and believed that exosomes are just a tool for the "excretion" of cells into the external environment. In 2007, Valadi et al.
proposed that exosomes contain mRNA and miRNA and can transmit them to another cell. Since then, the functions and mechanisms of exosomes started to be extensively studied. Exosomes exist in various body fluid environments such as serum, urine, saliva, milk and amniotic fluid.
Exosomes in biological fluids indicate the functional states of their origin cells, and can be used as bio-diagnostic markers for liver cancer, prostate cancer and other diseases in medicine. Since the membrane structures of exosomes can also be used as a drug carrier to exhibit high-efficiency drug delivery characteristics, for example, exosomes where unstable curcumin are loaded can improve the therapeutic effect.
Milk-derived exosomes are small vesicles secreted by mammary epithelial cells, and their main components are proteins, lipids and nucleic acids. The membrane surfaces of milk-derived exosomes have specific membrane proteins, such as the most abundant tetraspanins (CD9, CD82, CD81 and CD63), co-stimulatory molecules (CD54) and adhesion molecules (CD11b). Lipids (phosphatidylcholine, phosphatidylserine, phosphatidylethanolarnine, sphingomyelin, and phosphatidylinositol) are also commonly found in exosomes. Nucleic acids in milk-derived exosomes mainly comprise non-coding single-stranded RNA molecules (micro RNA, miRNA), long non-coding RNA (lncRNA), circular RNA (circRNA), mRNA and tRNA, etc. Milk-derived Date Recue/Date Received 2023-06-30 exosomes play an important role in physiological processes, such as mediating cell communication, promoting cell growth, and participating in immune responses.
At present, the commonly used exosome separation technology is centrifugation, but centrifugation would damage the morphologies of exosomes.
In view of this, the present application is hereby provided.
Summary of the Invention In order to solve the existing technical problems, the present application provides a new method for extracting milk-derived exosomes, and the method has little influence on the morphologies of exosomes.
In order to achieve the above-mentioned object, the technical solution used in the present application is as follows:
In a first aspect, the present application provides a method for extracting milk-derived exosomes.
The method sequentially comprises the following steps:
(1) Subpackaging and centrifuging raw milk, and collecting a clear liquid;
(2) Centrifuging the clear liquid obtained in step (1), and collecting a clear liquid in the middle layer;
(3) Centrifuging the clear liquid in the middle layer obtained in step (2), collecting a clear liquid, mixing the collected clear liquid with a PBS buffer solution and an exosome extraction reagent uniformly, and performing incubation;
(4) Centrifuging the product of step (3), retaining the precipitate, and re-suspending the precipitate with a PBS buffer solution; and
(5) Centrifuging the product of step (4) and collecting the supernatant to obtain the milk-derived exosome.
Preferably or optionally, the centrifuging process in step (1) is performed at room temperature, 1500-2500 X g for 5-15 min.
Preferably or optionally, the centrifuging process in step (2) is performed at room temperature, 8500-10000 X g for 25-35 mm, preferably 30 mm.
Preferably or optionally, the centrifuging process in step (3) is performed at room temperature, 8500-10000 X g for 25-35 mm, preferably 30 mm.
Date Recue/Date Received 2023-06-30 Preferably or optionally, in step (3), the volume ratio of the clear liquid to the PBS buffer solution to the exosome extraction reagent is 1: 1: 1.
Preferably or optionally, the exosome extraction reagent is a total exosome separation reagent produced by the Thenno Fisher company.
Preferably or optionally, in step (3), the incubation time is 25-35 min, preferably 30 min.
Preferably or optionally, the centrifuging process in step (4) is peifonned at room temperature, 8500-10000X g for 9-11 min, preferably 10 min.
Preferably or optionally, the centrifuging process in step (5) is peifonned at room temperature, 8500-10000 X g for 4-6 min, preferably 5 min.
In a second aspect, the present application further provides a milk-derived exosome which is prepared by the above-mentioned extraction method.
BENEFICIAL EFFECTS
Compared with milk-derived exosomes prepared by other methods, the milk-derived exosome prepared by the method for extracting milk-derived exosomes provided in the present application is more complete in morphology, requires less sample volume, and contains more types of milk-derived exosome proteins after separation, which is more conducive to analysis and research work.
Brief Description of the Drawings FIG. 1 is a transmission electron microscope image of the milk-derived exosome prepared in Example 1;
FIG. 2 is a transmission electron microscope image of the milk-derived exosome prepared in Example 2;
FIG. 3 is a transmission electron microscope image of the milk-derived exosome prepared in Comparative Example 1;
FIG. 4 is a transmission electron microscope image of the milk-derived exosome prepared in Comparative Example 2;
FIG. 5 is a transmission electron microscope image of the milk-derived exosome prepared in comparative example 3;
FIG. 6 is a transmission electron microscope image of the milk-derived exosome prepared in Date Recue/Date Received 2023-06-30 Comparative Example 4;
FIG. 7 is a Venn diagram showing the types of exosome proteins obtained by the separation of milk-derived exosomes prepared in Example 1 and Comparative Examples 1 and 3.
Detailed Description of the Invention In order to facilitate understanding of the present application, the present application is more comprehensively described in detail in conjunction with the drawings and preferred experimental examples of the description, but the scope of protection of the present application is not limited to the following specific examples.
Unless otherwise defined, all technical terms used hereinafter have the same meaning as that commonly understood by a person skilled in the art. The technical terms used herein are only for the purpose of describing specific examples, and are not intended to limit the scope of protection of the present application.
Unless otherwise specified, all kinds of raw materials, reagents, instruments and equipment used in the present application can be purchased from the market or prepared by existing methods.
Example 1 This example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
Raw milk was subpackaged into 1 mL centrifuge tubes, 1 mL of sample per tube, and centrifuged at room temperature, 2000 X g for 10 min, and a clear liquid was collected after centrifugation was completed. Centrifugation was performed again at room temperature, 10000 X
g for 30 min, and a clear liquid in the middle layer was collected.
The clear liquid in the middle layer was centrifuged at room temperature, 10000X g for 30 min, and then 200 1, of clear liquid was collected and mixed with 200 I, of a PBS
buffer solution.
Then, 200 pl of a total exosome separation reagent produced by the Thenno Fisher company was added, the mixture was mixed uniformly and subjected to incubation and reaction for 30 min, then centrifugation was performed at room temperature, 10000 X g for 10 min, and the precipitate was collected.
Date Recue/Date Received 2023-06-30 The precipitate was resuspended with 50 1., of a PBS buffer solution, centrifuged at 10000 X g for 5min at room temperature, and the supematant was collected to obtain an extracted exosome.
Example 2 This example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from ilactou milk powder produced by Beijing Sanyuan Foods Co., Ltd.
The extraction process in Example 2 is the same as that in Example 1.
Comparative Example 1 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
Raw milk was subpackaged into 1 mL centrifuge tubes, 1 mL of sample per tube, and centrifuged at room temperature, 2000 X g for 10 min, and a clear liquid was collected after centrifugation was completed. Centrifugation was performed again at room temperature, 10000 X
g for 30 min, and a clear liquid in the middle layer was collected.
The clear liquid in the middle layer was centrifuged at room temperature, 10000 X g for 30 min, and then 200 1t1, of clear liquid was collected and mixed with 200 tiL of a PBS buffer solution.
Then, 200 1iL of a high-efficiency exosome precipitation reagent produced by Invent Biotechnologies (Beijing), Inc. was added, the resulting mixture was mixed uniformly and subjected to incubation and reaction at room temperature for 30 min, centrifugation was performed at room temperature, 10000 X g for 10 min, and the precipitate was collected.
The precipitate was resuspended with 50 [IL of a PBS buffer solution, centrifuged at room temperature, 10000X g for 5 min, and the supernatant was collected to obtain an extracted exosome.
Comparative Example 2 This comparative example provides a method for extracting a milk-derived exosome.
Date Recue/Date Received 2023-06-30 The raw milk of the milk-derived exosome is derived from ilactou milk powder produced by Beijing Sanyuan Foods Co., Ltd.
The extraction process of Comparative Example 2 was the same as that of Comparative Example 1.
Comparative Example 3 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
50 mL of raw milk was placed in an ultracentrifuge tube and centrifuged at 4 C, 3000 rpm for 60 min, the supernatant was collected and centrifuged at 4 C, 16000 rpm for 20 min, the fat on the surface was removed, a clear liquid was collected and centrifuged at 4 C, 30000 rpm for 60 min, and loose particles were collected.
The collected loose particles were re-suspended with PBS, then dissolved with a 0.3 mol/L
sucrose solution and centrifuged at 4 C, 20000 rpm for 120 min, the precipitate was collected, re-suspended with PBS and then filtered via a 0.22 membrane, and a clear liquid obtained after filtration was collected to obtain an exosome.
Comparative Example 4 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
50 mL of raw milk was placed in an ultracentrifuge tube and centrifuged at 4 C, 3000 rpm for 60 min, the supernatant was collected and centrifuged at 4 C, 16000 rpm for 20 min, the fat on the surface was removed, and a clear liquid was collected.
200 jtL of clear liquid was mixed uniformly with 200 pl of a PBS buffer solution, then 200 111, of a high-efficiency exosome precipitation reagent produced by Invent Biotechnologies (Beijing), Inc. was added, and the resulting mixture was mixed unifointly, subjected to incubation and reaction at room temperature for 30 min, and then centrifuged at room temperature, 10000 X g
Preferably or optionally, the centrifuging process in step (1) is performed at room temperature, 1500-2500 X g for 5-15 min.
Preferably or optionally, the centrifuging process in step (2) is performed at room temperature, 8500-10000 X g for 25-35 mm, preferably 30 mm.
Preferably or optionally, the centrifuging process in step (3) is performed at room temperature, 8500-10000 X g for 25-35 mm, preferably 30 mm.
Date Recue/Date Received 2023-06-30 Preferably or optionally, in step (3), the volume ratio of the clear liquid to the PBS buffer solution to the exosome extraction reagent is 1: 1: 1.
Preferably or optionally, the exosome extraction reagent is a total exosome separation reagent produced by the Thenno Fisher company.
Preferably or optionally, in step (3), the incubation time is 25-35 min, preferably 30 min.
Preferably or optionally, the centrifuging process in step (4) is peifonned at room temperature, 8500-10000X g for 9-11 min, preferably 10 min.
Preferably or optionally, the centrifuging process in step (5) is peifonned at room temperature, 8500-10000 X g for 4-6 min, preferably 5 min.
In a second aspect, the present application further provides a milk-derived exosome which is prepared by the above-mentioned extraction method.
BENEFICIAL EFFECTS
Compared with milk-derived exosomes prepared by other methods, the milk-derived exosome prepared by the method for extracting milk-derived exosomes provided in the present application is more complete in morphology, requires less sample volume, and contains more types of milk-derived exosome proteins after separation, which is more conducive to analysis and research work.
Brief Description of the Drawings FIG. 1 is a transmission electron microscope image of the milk-derived exosome prepared in Example 1;
FIG. 2 is a transmission electron microscope image of the milk-derived exosome prepared in Example 2;
FIG. 3 is a transmission electron microscope image of the milk-derived exosome prepared in Comparative Example 1;
FIG. 4 is a transmission electron microscope image of the milk-derived exosome prepared in Comparative Example 2;
FIG. 5 is a transmission electron microscope image of the milk-derived exosome prepared in comparative example 3;
FIG. 6 is a transmission electron microscope image of the milk-derived exosome prepared in Date Recue/Date Received 2023-06-30 Comparative Example 4;
FIG. 7 is a Venn diagram showing the types of exosome proteins obtained by the separation of milk-derived exosomes prepared in Example 1 and Comparative Examples 1 and 3.
Detailed Description of the Invention In order to facilitate understanding of the present application, the present application is more comprehensively described in detail in conjunction with the drawings and preferred experimental examples of the description, but the scope of protection of the present application is not limited to the following specific examples.
Unless otherwise defined, all technical terms used hereinafter have the same meaning as that commonly understood by a person skilled in the art. The technical terms used herein are only for the purpose of describing specific examples, and are not intended to limit the scope of protection of the present application.
Unless otherwise specified, all kinds of raw materials, reagents, instruments and equipment used in the present application can be purchased from the market or prepared by existing methods.
Example 1 This example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
Raw milk was subpackaged into 1 mL centrifuge tubes, 1 mL of sample per tube, and centrifuged at room temperature, 2000 X g for 10 min, and a clear liquid was collected after centrifugation was completed. Centrifugation was performed again at room temperature, 10000 X
g for 30 min, and a clear liquid in the middle layer was collected.
The clear liquid in the middle layer was centrifuged at room temperature, 10000X g for 30 min, and then 200 1, of clear liquid was collected and mixed with 200 I, of a PBS
buffer solution.
Then, 200 pl of a total exosome separation reagent produced by the Thenno Fisher company was added, the mixture was mixed uniformly and subjected to incubation and reaction for 30 min, then centrifugation was performed at room temperature, 10000 X g for 10 min, and the precipitate was collected.
Date Recue/Date Received 2023-06-30 The precipitate was resuspended with 50 1., of a PBS buffer solution, centrifuged at 10000 X g for 5min at room temperature, and the supematant was collected to obtain an extracted exosome.
Example 2 This example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from ilactou milk powder produced by Beijing Sanyuan Foods Co., Ltd.
The extraction process in Example 2 is the same as that in Example 1.
Comparative Example 1 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
Raw milk was subpackaged into 1 mL centrifuge tubes, 1 mL of sample per tube, and centrifuged at room temperature, 2000 X g for 10 min, and a clear liquid was collected after centrifugation was completed. Centrifugation was performed again at room temperature, 10000 X
g for 30 min, and a clear liquid in the middle layer was collected.
The clear liquid in the middle layer was centrifuged at room temperature, 10000 X g for 30 min, and then 200 1t1, of clear liquid was collected and mixed with 200 tiL of a PBS buffer solution.
Then, 200 1iL of a high-efficiency exosome precipitation reagent produced by Invent Biotechnologies (Beijing), Inc. was added, the resulting mixture was mixed uniformly and subjected to incubation and reaction at room temperature for 30 min, centrifugation was performed at room temperature, 10000 X g for 10 min, and the precipitate was collected.
The precipitate was resuspended with 50 [IL of a PBS buffer solution, centrifuged at room temperature, 10000X g for 5 min, and the supernatant was collected to obtain an extracted exosome.
Comparative Example 2 This comparative example provides a method for extracting a milk-derived exosome.
Date Recue/Date Received 2023-06-30 The raw milk of the milk-derived exosome is derived from ilactou milk powder produced by Beijing Sanyuan Foods Co., Ltd.
The extraction process of Comparative Example 2 was the same as that of Comparative Example 1.
Comparative Example 3 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
50 mL of raw milk was placed in an ultracentrifuge tube and centrifuged at 4 C, 3000 rpm for 60 min, the supernatant was collected and centrifuged at 4 C, 16000 rpm for 20 min, the fat on the surface was removed, a clear liquid was collected and centrifuged at 4 C, 30000 rpm for 60 min, and loose particles were collected.
The collected loose particles were re-suspended with PBS, then dissolved with a 0.3 mol/L
sucrose solution and centrifuged at 4 C, 20000 rpm for 120 min, the precipitate was collected, re-suspended with PBS and then filtered via a 0.22 membrane, and a clear liquid obtained after filtration was collected to obtain an exosome.
Comparative Example 4 This comparative example provides a method for extracting a milk-derived exosome.
The raw milk of the milk-derived exosome is derived from a fresh milk delivery truck of Beijing Sanyuan Foods Co., Ltd.
50 mL of raw milk was placed in an ultracentrifuge tube and centrifuged at 4 C, 3000 rpm for 60 min, the supernatant was collected and centrifuged at 4 C, 16000 rpm for 20 min, the fat on the surface was removed, and a clear liquid was collected.
200 jtL of clear liquid was mixed uniformly with 200 pl of a PBS buffer solution, then 200 111, of a high-efficiency exosome precipitation reagent produced by Invent Biotechnologies (Beijing), Inc. was added, and the resulting mixture was mixed unifointly, subjected to incubation and reaction at room temperature for 30 min, and then centrifuged at room temperature, 10000 X g
6 Date Recue/Date Received 2023-06-30 for 10 mm, and the precipitate was collected.
The precipitate was re-suspended with 50 irt of a PBS buffer solution, centrifuged at room temperature, 10000 X g for 5 min, and the supernatant was collected to obtain an extracted exosome.
Effect Example 1 The morphologies of the milk-derived exosomes obtained in Examples 1-2 and Comparative Examples 1-4 were observed under a transmission electron microscope (TEM), and the results are shown in FIGs. 1-6.
As can be seen from FIGs. 1-6, the milk-derived exosomes obtained in Examples 1-2 and Comparative Examples 1-3 all have a diameter range of 30-150 nm, and all have cup-shaped double-layer membrane structures. The milk-derived exosomes obtained by the methods provided in Comparative Examples 2-3 are incomplete in morphology and have a messy background, whereas the milk-derived exosomes obtained by the methods in Comparative Example 1 and Example 1 are very complete in morphology and show a complete "cup and plate" structure. The milk-derived exosome obtained by the method in Comparative Example 4 is completely broken.
Effect Example 2 The milk-derived exosomes obtained in Example 1 and Comparative Examples 1 and 3 were respectively treated, and the specific treatment method was as follows: 100 trI, of 0.1% RapiGest SF reagent produced by the Waters company was added to the milk-derived exosome, the resulting liquid was mixed uniformly, and the resulting mixture was ultrasonically dissolved for 30 min; then 100 fiL of DTI' reagent was added, and the resulting mixture was placed in a water bath at 56 C for 1 h; after the reaction was completed, the resulting product was cooled down to room temperature naturally, 1001.IL of 0.1 mol/L IAA was added, and reaction was performed in the dark for 40 min; then 50 mt of 1 mg/mL trypsin was added, enzyme digestion was performed overnight, and typsin was added once more halfway; after the enzymatic hydrolysis was completed, an appropriate amount of 0.5 mol/L HCl was added to terminate the reaction for 50 mm, and the RapiGest SF reagent was made to precipitate; and desalting treatment was performed with an HLB column, the precipitate produced by the RapiGest SF
reagent was removed under an acidic condition, the sample was collected, lyophilization was performed, the lyophilized sample was redissolved with a 0.1% formic acid aqueous solution, centrifugation was performed at 10000X g for 10 min, and the supernatant was collected for later use.
The precipitate was re-suspended with 50 irt of a PBS buffer solution, centrifuged at room temperature, 10000 X g for 5 min, and the supernatant was collected to obtain an extracted exosome.
Effect Example 1 The morphologies of the milk-derived exosomes obtained in Examples 1-2 and Comparative Examples 1-4 were observed under a transmission electron microscope (TEM), and the results are shown in FIGs. 1-6.
As can be seen from FIGs. 1-6, the milk-derived exosomes obtained in Examples 1-2 and Comparative Examples 1-3 all have a diameter range of 30-150 nm, and all have cup-shaped double-layer membrane structures. The milk-derived exosomes obtained by the methods provided in Comparative Examples 2-3 are incomplete in morphology and have a messy background, whereas the milk-derived exosomes obtained by the methods in Comparative Example 1 and Example 1 are very complete in morphology and show a complete "cup and plate" structure. The milk-derived exosome obtained by the method in Comparative Example 4 is completely broken.
Effect Example 2 The milk-derived exosomes obtained in Example 1 and Comparative Examples 1 and 3 were respectively treated, and the specific treatment method was as follows: 100 trI, of 0.1% RapiGest SF reagent produced by the Waters company was added to the milk-derived exosome, the resulting liquid was mixed uniformly, and the resulting mixture was ultrasonically dissolved for 30 min; then 100 fiL of DTI' reagent was added, and the resulting mixture was placed in a water bath at 56 C for 1 h; after the reaction was completed, the resulting product was cooled down to room temperature naturally, 1001.IL of 0.1 mol/L IAA was added, and reaction was performed in the dark for 40 min; then 50 mt of 1 mg/mL trypsin was added, enzyme digestion was performed overnight, and typsin was added once more halfway; after the enzymatic hydrolysis was completed, an appropriate amount of 0.5 mol/L HCl was added to terminate the reaction for 50 mm, and the RapiGest SF reagent was made to precipitate; and desalting treatment was performed with an HLB column, the precipitate produced by the RapiGest SF
reagent was removed under an acidic condition, the sample was collected, lyophilization was performed, the lyophilized sample was redissolved with a 0.1% formic acid aqueous solution, centrifugation was performed at 10000X g for 10 min, and the supernatant was collected for later use.
7 Date Recue/Date Received 2023-06-30 The treated milk-derived exosomes were detected by using nanoliter liquid chromatography connected in series with Q Exactive Orbitrap mass spectrometer, and a Venn diagram showing the types of proteins was plotted according to the detection results, as shown in FIG. 7.
As can be seen from FIG. 7, the milk-derived exosome prepared in Example 1 can be separated to obtain 315 kinds of bovine milk exosome proteins, the milk-derived exosome prepared in Comparative Example 1 can be separated to obtain 267 kinds of bovine milk exosome proteins, and the milk-derived exosome prepared in Comparative Example 3 can be separated to obtain 307 kinds of bovine milk exosome proteins.
In summary, compared with a traditional high-speed centrifugation method, the method for extracting milk-derived exosomes provided in the present application has the advantages that the prepared milk-derived exosome is more complete in morphology and requires less sample volume by means of the optimization of the process and the selection of reagent. Compared with similar reagents, the prepared milk-derived exosome can obtain more types of exosome proteins after separation and thus is more suitable for subsequent analysis of exosome proteomics.
Finally, it should be noted that: the above-mentioned examples are only used to illustrate the technical solution of the present application, rather than to limit them.
Although the present application is described in detail with reference to the foregoing examples, a person skilled in the art should understand that it is still possible to amend the technical solutions described in the foregoing examples or to make equivalent replacements to some of the technical features thereof;
and these amendments or replacements should not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the examples of the present application.
INDUSTRIAL PRACTICABILITY
The present application relates to a method for extracting milk-derived exosomes. Compared with milk-derived exosomes prepared by other methods, the milk-derived exosome prepared by the method for extracting a milk-derived exosome provided in the present application is more complete in morphology, requires less sample volume, and contains more types of milk-derived exosome proteins after separation, which is more conducive to analysis and research work.
As can be seen from FIG. 7, the milk-derived exosome prepared in Example 1 can be separated to obtain 315 kinds of bovine milk exosome proteins, the milk-derived exosome prepared in Comparative Example 1 can be separated to obtain 267 kinds of bovine milk exosome proteins, and the milk-derived exosome prepared in Comparative Example 3 can be separated to obtain 307 kinds of bovine milk exosome proteins.
In summary, compared with a traditional high-speed centrifugation method, the method for extracting milk-derived exosomes provided in the present application has the advantages that the prepared milk-derived exosome is more complete in morphology and requires less sample volume by means of the optimization of the process and the selection of reagent. Compared with similar reagents, the prepared milk-derived exosome can obtain more types of exosome proteins after separation and thus is more suitable for subsequent analysis of exosome proteomics.
Finally, it should be noted that: the above-mentioned examples are only used to illustrate the technical solution of the present application, rather than to limit them.
Although the present application is described in detail with reference to the foregoing examples, a person skilled in the art should understand that it is still possible to amend the technical solutions described in the foregoing examples or to make equivalent replacements to some of the technical features thereof;
and these amendments or replacements should not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the examples of the present application.
INDUSTRIAL PRACTICABILITY
The present application relates to a method for extracting milk-derived exosomes. Compared with milk-derived exosomes prepared by other methods, the milk-derived exosome prepared by the method for extracting a milk-derived exosome provided in the present application is more complete in morphology, requires less sample volume, and contains more types of milk-derived exosome proteins after separation, which is more conducive to analysis and research work.
8 Date Recue/Date Received 2023-06-30
Claims (10)
1. A method for extracting milk-derived exosomes, wherein the method sequentially comprises the following steps:
(1) Subpackaging and centrifuging raw milk, and collecting a clear liquid;
(2) Centrifuging the clear liquid obtained in step (1), and collecting a clear liquid in the middle layer;
(3) Centrifuging the clear liquid in the middle layer obtained in step (2), collecting a clear liquid, mixing the clear liquid with a PBS buffer solution and an exosome extraction reagent uniformly, and performing incubation;
(4) Centrifuging the product of step (3), retaining the precipitate, and re-suspending the precipitate with a PBS buffer solution; and (5) Centrifuging the product of step (4) and collecting the supernatant to obtain the milk-derived exosome.
(1) Subpackaging and centrifuging raw milk, and collecting a clear liquid;
(2) Centrifuging the clear liquid obtained in step (1), and collecting a clear liquid in the middle layer;
(3) Centrifuging the clear liquid in the middle layer obtained in step (2), collecting a clear liquid, mixing the clear liquid with a PBS buffer solution and an exosome extraction reagent uniformly, and performing incubation;
(4) Centrifuging the product of step (3), retaining the precipitate, and re-suspending the precipitate with a PBS buffer solution; and (5) Centrifuging the product of step (4) and collecting the supernatant to obtain the milk-derived exosome.
2. The method for extracting milk-derived exosomes according to claim 1, wherein the centrifuging process in step (1) is performed at room temperature, 1500-2500 X
g for 5-15 min.
g for 5-15 min.
3. The method for extracting milk-derived exosomes according to claim 1, wherein the centrifuging process in step (2) is performed at room temperature, 8500-10000 X g for 25-35 min, preferably 30 min.
4. The method for extracting milk-derived exosomes according to claim 1, wherein the centrifuging process in step (3) is performed at room temperature, 8500-10000 X g for 25-35 min, preferably 30 min.
5. The method for extracting milk-derived exosomes according to claim 1, wherein in step (3), the volume ratio of the clear liquid to the PBS buffer solution to the exosome extraction reagent is 1 : 1 : 1.
6. The method for extracting milk-derived exosomes according to claim 5, wherein the exosome extraction reagent is a total exosome separation reagent produced by the Thermo Fisher company.
7. The method for extracting milk-derived exosomes according to claim 1, wherein in step (3), the incubation time is 25-35 min, preferably 30 min.
Date Recue/Date Received 2023-06-30
Date Recue/Date Received 2023-06-30
8. The method for extracting milk-derived exosomes according to claim 1, wherein the centrifuging process in step (4) is performed at room temperature, 8500-10000 X g for 9-11 min, preferably 10 min.
9. The method for extracting milk-derived exosomes according to claim 1, wherein the centrifuging process in step (5) is performed at room temperature, 8500-10000 X g for 4-6 min, preferably 5 min.
10. A milk-derived exosome, wherein the milk-derived exosome is prepared by the extraction method according to any one of claims 1-9.
Date Recue/Date Received 2023-06-30
Date Recue/Date Received 2023-06-30
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210755949.7 | 2022-06-30 | ||
CN202210755949.7A CN114891723B (en) | 2022-06-30 | 2022-06-30 | Milk-derived exosome and extraction method |
PCT/CN2023/089769 WO2024001457A1 (en) | 2022-06-30 | 2023-04-21 | Milk-derived exosome and extraction method |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3205241A1 true CA3205241A1 (en) | 2023-12-30 |
Family
ID=89324641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3205241A Pending CA3205241A1 (en) | 2022-06-30 | 2023-04-21 | Milk-derived exosome and extraction method therefor |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA3205241A1 (en) |
-
2023
- 2023-04-21 CA CA3205241A patent/CA3205241A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020103192A1 (en) | Method for extracting exosome | |
US20220372173A1 (en) | Lectin-magnetic carrier coupling complex for separating glycosylated exosomes from clinical sample | |
CN117286094B (en) | Preparation method and application of exosome derived from human organ | |
Lachmann et al. | Complement-mediated lysis of liposomes produced by thereactive lysis' procedure | |
CN112501112A (en) | Separation and enrichment method for rapidly extracting tissue extracellular vesicles | |
WO2024001457A1 (en) | Milk-derived exosome and extraction method | |
WO2019160519A2 (en) | Exosome isolation method by two phase fluid system | |
CN109207425A (en) | Porphyromonas gingivalis inducing macrophage excretion body rna expression research method | |
Sheller-Miller et al. | Isolation and characterization of human amniotic fluid-derived exosomes | |
CA3205241A1 (en) | Milk-derived exosome and extraction method therefor | |
CN113215079B (en) | Method for extracting extracellular vesicles from milk | |
CN111534476B (en) | Method for dissociating and separating spermatids of shellfish spermary | |
NL2034093B1 (en) | Method for separating exosomes from apostichopus japonicus body fluid sample | |
CN117165595A (en) | Extracellular vesicle separation and enrichment nucleic acid capture object and preparation method of extracellular vesicle | |
KR102148298B1 (en) | Method for preparing nano particle-free cell culture media | |
David et al. | Antibacterial action of colistin (polymyxin E) against Mycobacterium aurum | |
WO2023067490A1 (en) | Extracellular vesicles derived from milk and process for isolating the same | |
CN212688058U (en) | Cell membrane nanometer vesicle filters collection device | |
Joplin et al. | Human intrahepatic biliary epithelial cell lineages: studies in vitro | |
CN104012991A (en) | Method for preparing eugenol nanoliposomes through alcohol injection-dynamic high-pressure microfluidization | |
CN112538459A (en) | Method for separating exosome in liver cancer tissue | |
CN114657125B (en) | Method for separating single nucleus cell of shark, dilution of shark and use thereof | |
CN117512055B (en) | Liver tissue dissociation kit and dissociation method thereof | |
CN115404212B (en) | Small-particle-size nano cell membrane vesicle, preparation method, composition and kit | |
RU2803918C1 (en) | Method of producing purified cultured blood serum depleted in growth factors |